"Long-term Safety and Efficacy of Patisiran in Patients with hATTR Amyloidosis: Global OLE Study (730)." Neurology
94.15 Supplement
(2020):
730.
Web. 28 May. 2023.
Advertisement
The most widely read and highly cited peer-reviewed neurology journal
